Assessment of Renal and Liver Function Tests and Correlations With Quality of Life in Patients With Type 2 Diabetes in Karbala City Iraq
Abstract
The number of individuals afflicted with diabetes has increased dramatically this century. Quality of life in relation to health is subjective and varies from person to person based on their own history of experiences, perspectives, assumptions, and values. A person's emotional, psychological, and social health are all affected by these things. It is important for healthcare providers to understand the societal, psychological, and physiological impacts of long-term conditions like diabetes. More and more people are living with type 2 diabetes, a chronic metabolic disease that has a major influence on people's daily lives. Complications decrease patients' quality of life and raise the likelihood of negative outcomes such emergency department visits, hospitalizations, and death, which in turn effect healthcare spending and the sustainability of services. Objectives: This study aims to examine the correlation between quality of life and renal and liver function tests in individuals with type 2 diabetes. Methods: A cross-sectional study design was used to assess renal and liver function tests and correlation with quality of life in 200 people suffering from type 2 diabetes. The quality of life as it pertains to one's health was measured using the Arabic numeral 8. The assessment was conducted using a 5-point Likert scale, where responses could be given on a scale from 1 to 5. A lower score indicates good quality of life assessment because the scales are flipped for each part. Results: Overall, high creatinine significantly affected HRQoL in patients with diabetes, with patients' mean scores in all HRQoL domains being significantly higher (P < 0.001) than controls (P value = 0.02 < 0.05). We also found a highly significant correlation between alkaline phosphate and quality of life scores (p value = 0.008 < 0.01). Conclusions: there is a significant correlation between creatinine and quality of life ahigh concentration of creatinine lead to significantly lower health-related quality of life in various domains .in respect to liver function tests we obtained a highly significant correlation between alkaline phosphate and quality of life.
References
2. Alm NA. Prevalence of Depression among Type 2 Diabetic Patients Attending Diabetic Clinic at Primary Health Care Centers in Jeddah, Saudi Arabia. Archives of Medicine. 2018; 10(5). doi: 10.21767/1989-5216.1000282.
3. American Diabetes Association. Standards of Medical Care in Diabetes—2014. Diabetes Care. 2014; 37(Supplement_1): S14-S80. doi: 10.2337/dc14-S014.
4. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003; 289(19): 2560-2572. doi: 10.1001/jama.289.19.2560.
5. Diagnosis and Classification of Diabetes Mellitus,” Diabetes Care, vol. 34, no. Supplement_1, pp. S62–S69, Jan. 2014, doi: 10.2337/dc11-s062.
6. Doi Y, Ninomiya T, Hata J, et al. Liver Enzymes as a Predictor for Incident Diabetes in a Japanese Population: The Hisayama Study. Obesity. 2007; 15(7): 1841-1850. doi: 10.1038/oby.2007.218.
7. Friedrich MJ. Depression Is the Leading Cause of Disability Around the World. JAMA. 2017; 317(15): 1517. doi: 10.1001/jama.2017.3826.
8. G. Dong, L. Qu, X. Gong, B. Pang, W. Yan, and J. Wei, “Effect of Social Factors and the Natural Environment on the Etiology and Pathogenesis of Diabetes Mellitus,” International Journal of Endocrinology, vol. 2019, pp. 1–7, Jun. 2019, doi: 10.1155/2019/8749291.
9. Holman RR, Paul SK, Bethel MA, et al. 10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes. New England Journal of Medicine. 2008; 359(15): 1577-1589. doi: 10.1056/NEJMoa0806470.
10. Hong YS, Kim H, Zhao D, Cho A. Chronic Kidney Disease on Health-Related Quality of Life in Patients with Diabetes Mellitus: A National Representative Study. Journal of Clinical Medicine. 2021; 10(20): 4639. doi: 10.3390/jcm10204639.
11. Jaser SS, Whittemore R, Ambrosino JM, et al. Coping and Psychosocial Adjustment in Mothers of Young Children With Type 1 Diabetes. Children’s Health Care. 2009; 38(2): 91-106. doi: 10.1080/02739610902813229.
12. Khamseh ME, Baradaran HR, Javanbakht M, et al. Comparison of the CES-D and PHQ-9 depression scales in people with type 2 diabetes in Tehran, Iran. BMC Psychiatry. 2011; 11: 61. doi: 10.1186/1471-244X-11-61.
13. Lenters-Westra E, English E. Evaluating new HbA1c methods for adoption by the IFCC and NGSP reference networks using international quality targets. Clinical Chemistry and Laboratory Medicine (CCLM). 2017; 55(9). doi: 10.1515/cclm-2017-0109.
14. M. van den Bosch and A. Meyer-Lindenberg, “Environmental Exposures and Depression: Biological Mechanisms and Epidemiological Evidence,” Annual Review of Public Health, vol. 40, no. 1, pp. 239–259, Apr. 2019, doi: 10.1146/annurev-publhealth-040218-044106.
15. Mather KJ, Verma S, Anderson TJ. Improved Endothelial Function with Metformin in Type 2 Diabetes Mellitus. Journal of the American College of Cardiology. 2001; 37(5): 1344-1350. doi: 10.1016/S0735-1097(01)01148-1.
16. S. E. M. van Dijk et al., “Measurement properties of depression questionnaires in patients with diabetes: a systematic review,” Quality of Life Research, vol. 27, no. 6, pp. 1415–1430, Feb. 2018, doi: 10.1007/s11136-018-1782-y.
17. Stamler J, Vaccaro O, Neaton JD, et al. Diabetes, Other Risk Factors, and 12-yr Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention Trial. Diabetes Care. 1993; 16(2): 434-444. doi: 10.2337/diacare.16.2.434.
18. Sunny AK, Khanal VK, Sah RB, Ghimire A. Depression among people living with type 2 diabetes in an urbanizing community of Nepal. PLOS ONE. 2019; 14(6): e0218119. doi: 10.1371/journal.pone.0218119.
19. van den Bosch M, Meyer-Lindenberg A. Environmental Exposures and Depression: Biological Mechanisms and Epidemiological Evidence. Annual Review of Public Health. 2019; 40: 239-259. doi: 10.1146/annurev-publhealth-040218-044106.
20. van Dijk SEM, Adriaanse MC, van der Zwaan L, et al. Measurement properties of depression questionnaires in patients with diabetes: a systematic review. Quality of Life Research. 2018; 27(6): 1415-1430. doi: 10.1007/s11136-018-1782-y.
21. Vijan S. Type 2 Diabetes. Annals of Internal Medicine. 2010; 152(5): ITC31-ITC15. doi: 10.7326/0003-4819-152-5-201003020-01003.
22. Zare N, Khalilian M. The Prevalence of Depression in Patients with Diabetes Mellitus Type II in the Shahid Rahimi Hospital of Khorramabad, Iran. Epidemiology: Open Access. 2016; 6(3). doi: 10.4172/2161-1165.1000249.
